Eli Lilly tablet reduces body weight by 12.4%, trailing Novo’s Wegovy injectable

August 10, 2025

BIO 2026: A Saudi sovereign wealth fund business and Flagship sign a research partnership

June 29, 2026

EMA Committee Recommends Revoking EU Approval of Tavneos After Review of Supporting Trial Data

June 28, 2026

Must Read

Why Medical Affairs Teams Need New Skills for the Next Decade

July 1, 2026

Viridian Therapeutics’ Lumvoa Gets FDA Nod For Thyroid Eye Disease Treatment

July 1, 2026

Zymeworks to Acquire Theravance in $929 Million Deal

July 1, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

AstraZeneca Presents Phase 3 Efzimfotase Alfa Data in Pediatric Hypophosphatasia Studies

AbbVie and Genmab Report Positive Phase 3 Results for Epkinly Combination in Diffuse Large B-Cell Lymphoma

Vistagen Misses Second Phase 3 Social Anxiety Trial but Sees Potential Path Forward

Ollin Brings in $330M to Advance Eye Disease Drug Through Phase 3 Trial

Zymeworks to Acquire Theravance in $929 Million Deal

BIO 2026: A Saudi sovereign wealth fund business and Flagship sign a research partnership

Biogen Pens $1B Deal to Acquire RayThera, Bagging Preclinical Immunology Assets

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Why Medical Affairs Teams Need New Skills for the Next Decade

Top 10 Trends Reshaping Biotech R&D Infrastructure

The Rise of Multi-Omics in Drug Development

The Coming Talent Crisis in Life Sciences

Tag: Genmab

AbbVie and Genmab Report Positive Phase 3 Results for Epkinly Combination in Diffuse Large B-Cell Lymphoma

Editor Picks

Eli Lilly tablet reduces body weight by 12.4%, trailing Novo’s Wegovy injectable

BIO 2026: A Saudi sovereign wealth fund business and Flagship sign a research partnership

EMA Committee Recommends Revoking EU Approval of Tavneos After Review of Supporting Trial Data

Must Read

Why Medical Affairs Teams Need New Skills for the Next Decade

Viridian Therapeutics’ Lumvoa Gets FDA Nod For Thyroid Eye Disease Treatment

Zymeworks to Acquire Theravance in $929 Million Deal

Hot Topics

About Us

Follow Us